Case Report
Duodenal dieulafoy injury: case report
1Hospital Regional De Alta Especialidad De Veracruz, Veracruz, Mexico
2Universidad Autónoma De Durango, Campus Laguna, Gómez Palacio, Durango, Mexico
3Universidad de Montemorelos, Montemorelos, Mexico
4Universidad Juarez Del Estado De Durango, Durango, Mexico
5Universidad Nacional Autónoma De México FES Iztacala, Tlalnepantla de Baz, Mexico
6Hospital General Dr Ganiel Gurria Urgell, ISSSTE Villahermosa, Villahermosa, Mexico
Received: 26 November 2023
Accepted: 01 December 2023
*Correspondence:
Dr. Juan D. M. López,
E-mail: juandavid@gmail.com
Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
ABSTRACT
Dieulafoy's lesion is a rare but important cause of upper or lower gastrointestinal bleeding, resulting from bleeding from a large arterial vessel. Its extragastric location is rare and the diagnosis is usually endoscopic, allowing simultaneous treatment either with injection of sclerosing substances or by mechanical means. We present the case of a 72-year-old woman with severe gastrointestinal bleeding with Dieulafoy's lesion in the duodenal bulb, successfully diagnosed and treated endoscopically.
Keywords: General surgery, Dieulafoy injury, Case report
INTRODUCTION
Upper gastrointestinal hemorrhage secondary to a Dieulafoy lesion has a low incidence of 2 to 5%.1 75% of these lesions are located in the proximal stomach and the remaining 25% are extragastric, with duodenal, colonic and rectal lesions standing out in order of frequency.2,3
CASE REPORT
A 72-year-old woman with a history of liver failure for 15 years and chronic alcoholism since her youth, suspended more than 12 years ago, was admitted to the emergency department due to the presence of sudden hematemesis, as well as melenic evacuations.
On initial physical examination, the patient was in fair general condition, with the presence of generalized integumentary pallor, heart rate (HR): 112 bpm, respiratory rate (RR): 17 rpm, SaO2: 90%, A.R. of 80/60, oral cavity with blood remains, soft abdomen, not painful on palpation, no signs of peritoneal irritation and digital rectal examination with melenic traces.
Admission hemoglobin 5.3 g/dl and hematocrit of 15.9%, follow-up blood count 24 hours after transfusion of erythrocyte concentrates haemoglobin (Hb) 8.5 g/dl, haematocrit (Ht) 24.5%. Once the state of shock was subsided, upper gastrointestinal endoscopy was performed, and the following findings were reported: At the level of the duodenal knee, where the first and second portion are joined, a pulsatile bleeding vessel is observed on the posterior aspect (Figure 1) with a jet at the apex of the vessel whose vessel body emerges through a hole in the mucosa without ulcer about 0.5 cm in diameter and the Angled vessel reaches 4 mm in height towards the duodenal lumen.
Treatment
The application of an adrenaline solution (1:10,000) was carried out with a partial reduction in bleeding, so an injection of hystoacryl (Figure 2) was administered, corroborating the total hemostasis. Endoscopic control at 48 hours, with no data of active bleeding, only data of mucosal edema. Patient with satisfactory evolution was discharged with an appointment after outpatient consultation.
DISCUSSION
Described by Gallard in 1884 as a miliary aneurysm of the stomach; and later, by the French surgeon Georges Dieulafoy when he reported three fatal gastric hemorrhages in asymptomatic young men.4-6
Dieulafoy's lesion consists of a histologically normal, large arterial vessel that abnormally maintains its caliber (1-3 mm) along a sinuous path from the submucosa to the mucosa, where it penetrates through a minimal defect.2,3
The condition is well documented in patients aged between 50 and 70 years with a predominance of the male sex in a ratio of 2:1.7,8
The link between systemic diseases such as liver cirrhosis, chronic renal failure, and vascular lesions in the digestive system is well known. It is possible that this type of systemic disorder alters normal angiogenesis and conditions the appearance of aberrant arterial neovessels of persistent caliber that, under conditions of stress of the digestive mucosa, can erode and cause hemorrhage.9
These patients present acutely with massive and sometimes recurrent bleeding. The most common symptoms are massive hematemesis, melena, hematochezia, no abdominal pain.10
Initial endoscopy is effective in diagnosing up to 70%; however, more than one endoscopic examination may be required to establish the diagnosis.11
The proposed endoscopic criteria for defining LD are: active or micropulsatile arterial bleeding from a minimal mucosal defect with normal surrounding mucosa, visualization of a protruding vessel, with or without active bleeding, within a minimal mucosal defect or through the surrounding normal mucosa, and fresh clot, attached with a tight attachment point to a minimal mucosal defect or normal-appearing mucosa.12
Endoscopic management of these lesions has become the standard for treatment, with success rates as high as 95%.9
Endoscopic options range from the injection of adrenaline and/or sclerosing substances, the use of high-energy devices (electrocoagulation and laser photocoagulation), as well as mechanical therapy (hemoclips and band ligation).14-16
Currently, there is no consensus on the superiority of one method over another, and more than one author suggests the combination of mechanical and sclerotic therapy, thus reducing the incidence of rebleeding compared to monotherapy.17-19
Surgical resection is reserved for 5% of cases that are refractory to endoscopic management or angiographic methods.
CONCLUSION
Dieulafoy's lesion is a pathology that should be considered as a diagnosis in all patients with upper gastrointestinal bleeding, endoscopy is the method of choice for the diagnosis and treatment of this entity. Surgery is reserved for patients with uncontrollable bleeding with endoscopic and angiography embolization methods.
Funding: No funding sources
Conflict of interest: None declared
Ethical approval: Not required
REFERENCES
- 1. González-Sánchez CB, Orozco-Monroy G, Leycegui-Aiza M, Eljure M, Martínez de la Maza E. Artículo de revisión. Lesión de Dieulafoy, aspectos generales de diagnóstico y tratamiento. Endoscopia. 2010;22:161-5.
- 2. Molina-Infante J. Lesión de Dieulafoy esofágica resuelta mediante ligadura endoscópica con banda. Gastroenterol Hepatol. 2012;6:1-2.
- 3. Thimmapuram J, Shah M, Srour J. Esophageal Dieulafoy lesion: an unusual cause of GI bleeding. Gastrointest Endosc. 2011;73:1055-6.
- 4. Chaer R, Helton WS. Dieulafoy’s disease. Am Coll Surg. 2003;196:290-6.
- 5. Peumery JJ. Georges Dieulafoy (1839–1911) and the teaching of medicine in Paris at the hinge of the Second Empire and the Third Republic. Vesalius. 2004;10:74-7.
- 6. Ibrarullah M, Wagholikar GD. Dieulafoy’s lesion of duodenum: a case report. BMC Gastroenterol. 2003,31(3):2.
- 7. López-Ciudad V, Pato M, Cid J. Hemorragia digestiva alta por lesión de Dieulafoy. Med Intensiva. 2003;27:699-70.
- 8. Lee YT, Walmsley RS, Leong R, Sung J. Dieulafoy’s lesion. Review Article. Gastrointest Endosc. 2003;58:236-43.
- 9. Ibáñez A, Castro E, Fernández E, Baltar R. Aspectos clínicos y tratamiento endoscópico de la hemorragia digestiva por lesión de Dieulafoy. Rev Esp Enferm Dig. 2007;99:505-10.
- 10. Angélica Rojas D, Germán David Carvajal P. An Unusual Finding of a Dieulafoy’s Lesion in the Duodenum. Rev Col Gastroenterol. 2016;31(3).
- 11. Baxter M. Dieulafoy’s lesion: current trends in diagnosis and management. Ann R Coll Surg Engl. 2010;92(7):548-54.
- 12. Dy NM, Gostout CJ, Balm RK. Bleeding from the endoscopically-identified Dieulafoy lesion of the proximal small intestine and colon. Am J Gastroenterol. 1995;90(1):108-11.
- 13. Sone Y, Kumada T, Toyoda H. Endoscopic management and follow up of Dieulafoy lesion in the upper gastrointestinal tract. Endoscopy. 2005;37(5):449-53.
- 14. Yilmaz M, Ozutemiz O, Karasu Z, Ersoz G, Gunsar F, Batur Y. et al. Endoscopic injection therapy of bleeding Dieulafoy lesion of the stomach. Hepato-Gastroenterol. 2005;52:1622-5.
- 15. Chung IK, Kim EJ, Lee MS, Kim HS, Park SH, Lee MH, et al. Bleeding Dieulafoy’s lesions and the choice of endoscopic method: Comparing the hemostatic efficacy of mechanical and injection methods. Gastrointest Endosc. 2000;52(6):721-4.
- 16. Cheng CL, Liu NJ, Lee CS, Chen PC, Ho YP, Tang JH, et al. EndoscopicmanagementofDieulafoy lesions in acute nonvariceal upper gastrointestinal bleeding. Dig Dis Sci. 2004;49:1139-44.
- 17. Karaahmet F, Kılıncalp S, Coskun Y, Hamamci M, Akinci H, Ustun Y, et al. The efficiency of endoclips in maintaining the gastrointestinal bleeding-related Dieulafoy's lesion. Wien Klin Wochenschr. 2016;128(19-20):700-5.
- 18. Park CH, Sohn YH, Lee WS, Joo YE, Choi SK, Rew JS, Kim SJ. The usefulness of endoscopic hemoclipping for bleeding Dieulafoy lesions. Endoscopy. 2003;35(5):388-92.
- 19. Yamaguchi Y, Yamato T, Katsumi N, Imao Y, Aoki K, Morita Y, et al. Short-term and long-term benefits of endoscopic hemoclip application for Dieulafoy's lesion in the upper GI tract. Gastrointest Endosc. 2003;57(6):653-6.